Home > Insider Trading > Filing (0001209191-17-031676)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180262	Herbalife Ltd.	HLF	Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1472187	Edi Hienrich	800 W. Olympic Blvd. Suite 406 Los Angeles CA 90015	Svp/Managing Director Emea	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-05-09	24,000	$15.14	29,488	No	4	M	Direct
Common Stock	Disposition	2017-05-09	4,991	$72.81	24,497	No	4	D	Direct
Common Stock	Disposition	2017-05-09	10,378	$72.81	14,119	No	4	F	Direct
Common Stock	Disposition	2017-05-09	5,488	$73.00	8,631	No	4	S	Direct
Common Stock	Disposition	2017-05-11	8,631	$71.74	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2017-05-09	24,000	$0.00	24,000	$15.14

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-08-31	2019-08-31	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016.
The total number of shares has been adjusted to include 4,628 shares inadvertently omitted from prior reports.
The reporting person received 8,631 shares of common stock upon the net exercise of the 24,000 stock appreciation rights ("SARS"). The reporting person forfeited 4,991 shares of common stock underlying the SARS in payment of the exercise price and 10,378 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
This transaction was executed in multiple trades at prices ranging from $71.31 to $72.27. The price reported above reflects the average sale price of $72.27. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.